Human Metabolome Technologies, Inc. (TYO:6090)
Japan · Delayed Price · Currency is JPY 610.00
+4.00 (0.66%)
Oct 6, 2026, 12:40 PM JST
TYO:6090 Market Cap
TYO:6090 has a market cap or net worth of 3.37 billion as of October 6, 2026. Its market cap has decreased by -18.97% in one year.
Market Cap
3.37B
Enterprise Value
2.03B
Revenue
1.42B
Ranking
n/a
PE Ratio
17.00
Stock Price
610.00
ChartMarket Cap Chart
Since December 24, 2013, TYO:6090's market cap has decreased from 11.04B to 3.37B, a decrease of -69.46%. That is a compound annual growth rate of -8.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 3.37B | -9.75% |
| Dec 30, 2025 | 3.74B | 2.79% |
| Dec 30, 2024 | 3.63B | -4.00% |
| Dec 29, 2023 | 3.79B | -5.61% |
| Dec 30, 2022 | 4.01B | 5.39% |
| Dec 30, 2021 | 3.81B | -13.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PRISM BioLab Co.,LTD | 5.21B |
| Kringle Pharma | 5.12B |
| Noile-Immune Biotech | 4.95B |
| Chordia Therapeutics | 4.71B |
| Ribomic | 4.24B |
| Kohjin Bio | 4.23B |
| D. Western Therapeutics Institute | 4.14B |
| Transgenic Group | 4.03B |